CD&R, Merck GHI and McKesson Ventures to invest in M2GEN
Clayton, Dubilier & Rice, the Merck Global Health Innovation Fund and McKesson Ventures have invested in M2GEN, a cancer data and informatics platform.
Clayton, Dubilier & Rice, the Merck Global Health Innovation Fund and McKesson Ventures have invested in M2GEN, a cancer data and informatics platform.